Navigation Links
Smith & Nephew Launches VISIONAIRE(TM) Patient Matched Technology for Total Knee Replacement
Date:2/23/2009

Smith & Nephew is the first and only major medical device company to design, build and distribute this powerful new technology for patients suffering from advanced osteoarthritis of the knee. Other implant makers rely on systems designed and built by third parties.

About us

Smith & Nephew is a global medical technology business, specializing in Orthopaedic Reconstruction, Orthopaedic Trauma & Clinical Therapies, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The company has 8,800 employees and operates in 32 countries around the world. Annual Sales in 2007 were nearly $3.4 billion.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the US Private Securities Litigation Reform Act of 1995. In particular, statements regarding planned growth in our business and in our trading margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward- looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation and regulatory approvals) that could cause the actual results, performance or achievements of Smi
'/>"/>

SOURCE Smith & Nephew, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Texcel Medical Appoints Barry Smith as President, CEO
2. Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes
3. GlaxoSmithKline Reports Q4 and Year End Results 2008
4. January 2009 - Rahu Appoints David Greensmith to Non Executive Directo
5. Houlihan Smith Arranges Non-Control Equity Investment Into Sottera, Inc., dba NJOY, by Miri Pharma, Inc.
6. GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.
7. GlaxoSmithKline Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies, Inc.
8. AUDIO from Medialink and GlaxoSmithKline: FDA Approves Boostrix for Adults
9. GlaxoSmithKline Extends Tender Offer for Genelabs Technologies, Inc.
10. BioWa Licenses POTELLIGENT(R) Technology to GlaxoSmithKline for Use in Antibody Development and Commercialization
11. GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... ANTONIO , 23 de julio de 2014 ... (ADBI o la Compañía) ha anunciado hoy una ... Akron (ABIA o el Instituto), para ... ADBI, un dispositivo de terapia de señal bioeléctrica ... El Instituto, que tiene una importante ...
(Date:7/23/2014)... July 23, 2014 /PRNewswire/ - BioAmber Inc. (NYSE: ... producing sustainable chemicals, today announced that the underwriters of ... option to purchase an additional 420,000 shares of ... $12.00 per share, less underwriting discounts and commissions, ... offering of 2,800,000 shares of common stock, bringing ...
(Date:7/23/2014)... MENLO PARK, Calif. , July 23, 2014 /PRNewswire/ ... based investment firm, today announced the closing of Sofinnova ... $500 million and in excess of the initial fund ... on helping entrepreneurs build successful biotechnology companies. Consistent with ... companies with promising later stage clinical programs, along with ...
(Date:7/23/2014)... a2z Inc. announces that AACC will include ... in its 2014 Annual Meeting & Clinical Lab ... for July 29-31, 2014 in Chicago, IL at McCormick ... with global leaders in clinical chemistry, molecular diagnostics, mass ... breaking science in laboratory medicine. , ChirpE Photo Booth ...
Breaking Biology Technology:ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 2ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 3ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 4ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 5ADB International Group Inc. anuncia una asociación con Austen BioInnovation Institute 6BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 2BioAmber announces exercise in full of underwriters' option in connection with previously priced follow-on offering 3Sofinnova Raises $500 Million Biotech Venture Fund 2AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 2AACC Enhances Attendee Experience at Its 2014 Annual Meeting & Clinical Lab Expo with a2z-Powered ChirpE Photo Booth and Mobile App 3
... N.C., Jan. 5, 2012 Tengion, Inc. (NASDAQ: ... medicine, today announced it has completed the relocation ... to the Company,s existing facility in Winston-Salem, North ... previously announced restructuring, which was designed to fund ...
... SARASOTA, Fla., Jan. 5, 2012  George Miller developed an ... His doctor sent cell scrapings to a pathologist, and ... TMD Limited, a medical tourism company, squamous cell carcinoma ... humans and other animals.  Squamous cell ...
... Jan. 5, 2012  AtheroNova, (OTCQB: AHRO) ("AtheroNova"), a biotech company ... atherosclerotic plaque, announced today that it has appointed Johan M. ... Directors of the Company effective January 3, 2012. Mr. Spoor ... and Medical Committees of the Board. "I ...
Cached Biology Technology:Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina 2Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina 3Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina 4Squamous Cell Cancer Responds to SPDT Therapy 2Squamous Cell Cancer Responds to SPDT Therapy 3Squamous Cell Cancer Responds to SPDT Therapy 4AtheroNova Announces a New Board Member 2AtheroNova Announces a New Board Member 3
(Date:7/23/2014)... HOLE, MA -- What do mollusks, starfish, and ... marine habitat, they are all calcifiersorganisms that use ... skeletons and shells for stability and protection. , ... , published by the Marine Biological Laboratory, addresses ... composition changes worldwide. , As atmospheric carbon dioxide ...
(Date:7/23/2014)... the principal bacteria that cause dental caries, has ... time, possibly coinciding with dietary change linked to ... in a study by researchers from the Universitat ... de Genmica para la Biodiversidad (National Laboratory of ... first time, have sequenced genetic material from this ...
(Date:7/23/2014)... popular culinary herbs oregano and rosemary are packed with ... work in much the same way as prescription anti-diabetic ... ACS, Journal of Agricultural and Food Chemistry , ... a difference, and they also identified which compounds contribute ... de Mejia and colleagues point out that in 2012, ...
Breaking Biology News(10 mins):Calcification in changing oceans explored in special issue of The Biological Bulletin 2Ancient genetic material from caries bacterium obtained for the first time 2
... total energy used in the USA is taken up in ... comes from non-renewable energy sources which are in short supply. ... reducing this significant fuel consumption in the US food system ... the Springer journal Human Ecology , David Pimentel and ...
... CO, USA GEOLOGY topics include confirmation that ... a blowout in the Banjar Panji-1 well; evidence of the ... analysis of Yellowstone,s hotspot; and GPS measurements that show why ... GSA Today ,s science article studies the impact of Glen ...
... medicines and the introduction of new anti-arthritis drugs ... (RA), according to guidelines issued by the American ... the University of Alabama at Birmingham (UAB). ... in the UAB Division of Clinical Immunology and ...
Cached Biology News:Why eating less can help the environment 2August 2008 Geology and GSA Today media highlights 2August 2008 Geology and GSA Today media highlights 3August 2008 Geology and GSA Today media highlights 4August 2008 Geology and GSA Today media highlights 5August 2008 Geology and GSA Today media highlights 6August 2008 Geology and GSA Today media highlights 7August 2008 Geology and GSA Today media highlights 8August 2008 Geology and GSA Today media highlights 9August 2008 Geology and GSA Today media highlights 10August 2008 Geology and GSA Today media highlights 11August 2008 Geology and GSA Today media highlights 12New guidelines for treating rheumatoid arthritis 2
IRF7 Immunogen: Synthetic peptide corresponding to residues E(463) G T Q R E G V S S L D S S S(477) of human IRF7. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Rabbit polyclonal to NMDAR1 e/f/g/h ( Abpromise for all tested applications)....
Rabbit polyclonal to TetR ( Abpromise for all tested applications). Antigen: Synthetic peptide: AQKLGVEQPTLYWHVKNKR, corresponding to amino acids 31 - 49 of TetR...
Polyclonal Antibody to Coronin / CORO1C This antibody was developed against synthetic peptides corresponding to amino acids 407-420 of human CORO1C....
Biology Products: